Correlation Between Viridian Therapeutics and Mersana Therapeutics
Can any of the company-specific risk be diversified away by investing in both Viridian Therapeutics and Mersana Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Viridian Therapeutics and Mersana Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Viridian Therapeutics and Mersana Therapeutics, you can compare the effects of market volatilities on Viridian Therapeutics and Mersana Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Viridian Therapeutics with a short position of Mersana Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Viridian Therapeutics and Mersana Therapeutics.
Diversification Opportunities for Viridian Therapeutics and Mersana Therapeutics
0.66 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Viridian and Mersana is 0.66. Overlapping area represents the amount of risk that can be diversified away by holding Viridian Therapeutics and Mersana Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Mersana Therapeutics and Viridian Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Viridian Therapeutics are associated (or correlated) with Mersana Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Mersana Therapeutics has no effect on the direction of Viridian Therapeutics i.e., Viridian Therapeutics and Mersana Therapeutics go up and down completely randomly.
Pair Corralation between Viridian Therapeutics and Mersana Therapeutics
Given the investment horizon of 90 days Viridian Therapeutics is expected to under-perform the Mersana Therapeutics. But the stock apears to be less risky and, when comparing its historical volatility, Viridian Therapeutics is 2.81 times less risky than Mersana Therapeutics. The stock trades about -0.42 of its potential returns per unit of risk. The Mersana Therapeutics is currently generating about -0.08 of returns per unit of risk over similar time horizon. If you would invest 59.00 in Mersana Therapeutics on November 30, 2024 and sell it today you would lose (9.00) from holding Mersana Therapeutics or give up 15.25% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Significant |
Accuracy | 100.0% |
Values | Daily Returns |
Viridian Therapeutics vs. Mersana Therapeutics
Performance |
Timeline |
Viridian Therapeutics |
Mersana Therapeutics |
Viridian Therapeutics and Mersana Therapeutics Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Viridian Therapeutics and Mersana Therapeutics
The main advantage of trading using opposite Viridian Therapeutics and Mersana Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Viridian Therapeutics position performs unexpectedly, Mersana Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Mersana Therapeutics will offset losses from the drop in Mersana Therapeutics' long position.Viridian Therapeutics vs. Nuvalent | ||
Viridian Therapeutics vs. Arcellx | ||
Viridian Therapeutics vs. Vaxcyte | ||
Viridian Therapeutics vs. Crinetics Pharmaceuticals |
Mersana Therapeutics vs. Terns Pharmaceuticals | ||
Mersana Therapeutics vs. Amylyx Pharmaceuticals | ||
Mersana Therapeutics vs. Acumen Pharmaceuticals | ||
Mersana Therapeutics vs. Inozyme Pharma |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Center module to all portfolio management and optimization tools to improve performance of your portfolios.
Other Complementary Tools
ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk |